| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenue: | ||||||||
Net revenue | ||||||||
191,439 | - | - | - | 119,498 | - | - | - | - |
Costs and expenses: | ||||||||
Cost of net revenue | ||||||||
166,539 | - | - | - | 100,226 | - | - | - | - |
General and administrative expenses | ||||||||
14,346 | 40,415 | 1,195 | 1,798 | 13,082 | 17,464 | 391 | 162 | 50 |
Depreciation, excluding patient equipment depreciation | ||||||||
1,241 | - | - | - | 840 | - | - | - | - |
Total costs and expenses | ||||||||
182,128 | - | - | - | 114,150 | - | - | - | - |
State franchise taxes | ||||||||
- | - | 50 | 50 | - | - | 53 | 71 | 21 |
Operating income | ||||||||
9,310 | 27,442 | -1,245 | -1,848 | 5,348 | 31,842 | -444 | -234 | -72 |
Interest expense, net | ||||||||
7,938 | - | - | - | 6,260 | - | - | - | - |
Loss on extinguishment of debt | ||||||||
- | - | - | - | -2,121 | - | - | - | - |
Interest income | ||||||||
- | - | 1,367 | 1,482 | - | - | 1,204 | 1,156 | 364 |
Income (loss) before income taxes | ||||||||
1,372 | -8,450 | 122 | -366 | -3,033 | 20,264 | 760 | 922 | 292 |
Income tax expense | ||||||||
1,106 | -1,839 | 276 | 300 | 2,418 | -2,643 | 241 | 232 | 72 |
Net income (loss) | ||||||||
265 | - | - | - | -5,452 | - | - | - | - |
Income attributable to noncontrolling interest | ||||||||
423 | - | - | - | 348 | - | - | - | - |
Net loss attributable to AdaptHealth Corp. | ||||||||
-158 | -8,373 | -154 | -667 | -5,800 | 21,831 | 518 | 689 | 220 |
Net loss per common share: | ||||||||
Basic and diluted (per share) | ||||||||
- | - | - | - | -0.42 | - | - | - | - |
Weighted average shares outstanding for net loss attributable to AdaptHealth Corp.: | ||||||||
Basic and diluted (shares) | ||||||||
41,976 | - | - | - | 13,863 | - | - | - | - |
Basic and diluted weighted average Public Shares (Note 3) outstanding | ||||||||
- | - | 25,000 | 25,000 | - | - | 25,000 | 25,000 | 25,000 |
Basic and diluted net income per Public Share | ||||||||
- | - | 0.04 | 0.04 | - | - | 0.03 | 0.03 | 0.01 |
Basic and diluted weighted average Founder Shares (Note 4) outstanding | ||||||||
- | - | 6,250 | 6,250 | - | - | 6,250 | 6,250 | 6,250 |
Basic and diluted net loss per Founder Share | ||||||||
- | - | -0.19 | -0.25 | - | - | -0.02 | - | - |